Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Hematological Malignancies
Related studies linked through entity extraction aliases.
Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System
- Status
- UNKNOWN
- Phase
- N/A
Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
COVID19-hematological Malignancies: the Italian Hematology Alliance
- Status
- UNKNOWN
- Phase
- N/A
Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE3
Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials
- Status
- COMPLETED
- Phase
- PHASE1
Tissue Microarray of Hematological Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Durvalumab and Tremelimumab for Pediatric Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Cord Blood Transplantation With Myeloablative Conditioning and Post-transplant Cyclophosphamide (COmPACt Study)
- Status
- RECRUITING
- Phase
- N/A
Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Compassionate Use Study of Tenalisib (RP6530)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy Evaluation of IM19 Cells
- Status
- UNKNOWN
- Phase
- PHASE1
Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells
- Status
- RECRUITING
- Phase
- PHASE3